J. Goldman & Co LP - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,676,133
-27.9%
758,431
-17.2%
0.06%
-35.1%
Q1 2023$2,325,373
+2368.5%
915,501
+1717.4%
0.09%
+1780.0%
Q4 2022$94,201
-92.0%
50,375
-89.0%
0.01%
-91.1%
Q3 2022$1,180,000
+2925.6%
459,000
+2155.2%
0.06%
+2700.0%
Q2 2022$39,000
-98.8%
20,353
-98.1%
0.00%
-98.6%
Q1 2022$3,138,000
+621.4%
1,056,631
+1167.9%
0.14%
+429.6%
Q2 2020$435,000
-26.4%
83,334
-55.6%
0.03%
-62.0%
Q1 2020$591,000
+46.7%
187,755
+87.8%
0.07%
+144.8%
Q4 2019$403,000
-41.2%
100,000
-37.0%
0.03%
-43.1%
Q3 2019$685,000158,6500.05%
Other shareholders

There were no reported owners of PARATEK PHARMACEUTICALS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of PARATEK PHARMACEUTICALS INC shareholders